Clinical trials
Phase 3 Hypercholesterolemia trials in Norway
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 7 |
| 2014 | 2 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
| Active, not recruiting | 3 |
| Enrolling by invitation | 2 |
| Terminated | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 9 |
| Sanofi | 5 |
| Kowa Research Europe | 3 |
| LIB Therapeutics LLC | 3 |
| Merck Sharp & Dohme LLC | 3 |
| Regeneron Pharmaceuticals | 2 |
| AstraZeneca | 1 |
| Kastle Therapeutics, LLC | 1 |
| NewAmsterdam Pharma | 1 |
| Novartis Pharmaceuticals | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hypercholesterolemia | 30 |
| Dyslipidemias | 7 |
| Hyperlipidemias | 5 |
| Hyperlipoproteinemia Type II | 4 |
| Arteriosclerosis | 1 |
| Atherosclerosis | 1 |
| Genetic Diseases, Inborn | 1 |
| Homozygous Familial Hypercholesterolemia | 1 |
| Hyperlipoproteinemias | 1 |
| Lipid Metabolism Disorders | 1 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.